Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-18 4:49 pm Unchanged | 2025-12-31 | 13G | Dermata Therapeutics, Inc. DRMA | Armistice Capital, LLC | 53,910 4.990% | 0 (Unchanged) | Filing History |
| 2026-02-18 4:48 pm Unchanged | 2025-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX | Armistice Capital, LLC | 194,132 9.990% | 0 (Unchanged) | Filing History |
| 2026-02-18 4:47 pm Purchase | 2025-12-31 | 13G | Bicycle Therapeutics plc BCYC | Armistice Capital, LLC | 3,236,000 6.480% | 564,000 (+21.11%) | Filing History |
| 2026-02-18 4:46 pm Sale | 2025-12-31 | 13G | Alto Neuroscience, Inc. ANRO | Armistice Capital, LLC | 1,536,000 4.940% | -64,000 (-4.00%) | Filing History |
| 2026-02-18 11:15 am Sale | 2025-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | Armistice Capital, LLC | 4,000,000 7.190% | -200,000 (-4.76%) | Filing History |
| 2026-02-18 11:06 am Purchase | 2025-12-31 | 13G | Adial Pharmaceuticals, Inc. ADIL | Armistice Capital, LLC | 2,799,643 9.990% | 2,463,333 (+732.46%) | Filing History |
| 2026-02-17 9:55 pm Purchase | 2025-12-31 | 13G | Cycurion, Inc. Common Stock CYCU | Armistice Capital, LLC | 301,052 9.990% | 301,052 (New Position) | Filing History |
| 2026-02-17 9:55 pm Purchase | 2025-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX | Armistice Capital, LLC | 194,132 9.990% | 194,132 (New Position) | Filing History |
| 2026-02-17 9:55 pm Purchase | 2025-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX | Armistice Capital, LLC | 283,502 9.990% | 283,502 (New Position) | Filing History |
| 2026-02-17 9:54 pm Purchase | 2025-12-31 | 13G | Ascent Solar Technologies, Inc. Common Stock ASTI | Armistice Capital, LLC | 386,142 9.990% | 386,142 (New Position) | Filing History |
| 2026-02-17 9:54 pm Purchase | 2025-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Armistice Capital, LLC | 3,036,000 5.210% | 828,930 (+37.56%) | Filing History |
| 2026-02-17 9:54 pm Purchase | 2025-12-31 | 13G | Aethlon Medical, Inc. AEMD | Armistice Capital, LLC | 84,496 9.990% | 84,496 (New Position) | Filing History |
| 2026-02-17 9:53 pm Purchase | 2025-12-31 | 13G | Actelis Networks, Inc. ASNS | Armistice Capital, LLC | 917,950 4.990% | 917,950 (New Position) | Filing History |
| 2026-02-17 9:53 pm Unchanged | 2025-12-31 | 13G | AngioDynamics, Inc. ANGO | Armistice Capital, LLC | 1,624,000 6.000% | 0 (Unchanged) | Filing History |
| 2026-02-17 9:52 pm Purchase | 2025-12-31 | 13G | Citius Oncology, Inc. CTOR | Armistice Capital, LLC | 8,078,404 9.990% | 402,493 (+5.24%) | Filing History |
| 2026-02-17 9:52 pm Purchase | 2025-12-31 | 13G | Curis, Inc. CRIS | Armistice Capital, LLC | 1,336,876 9.990% | 290,387 (+27.75%) | Filing History |
| 2026-02-17 9:52 pm Purchase | 2025-12-31 | 13G | Avanos Medical, Inc. AVNS | Armistice Capital, LLC | 3,200,000 6.890% | 700,000 (+28.00%) | Filing History |
| 2026-02-17 9:51 pm Purchase | 2025-12-31 | 13G | Autolus Therapeutics plc AUTL | Armistice Capital, LLC | 17,500,000 6.580% | 1,900,000 (+12.18%) | Filing History |
| 2026-02-17 9:51 pm Unchanged | 2025-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS | Armistice Capital, LLC | 5,096,251 11.430% | 0 (Unchanged) | Filing History |
| 2026-02-17 9:50 pm Purchase | 2025-12-31 | 13G | INVO Fertility, Inc. IVF | Armistice Capital, LLC | 602,965 9.990% | 602,965 (New Position) | Filing History |